What is Godavari Drugs Ltd (530317) share price return in the past 10 years?

Godavari Drugs Ltd share price has appreciated 11.8% annually (CAGR) over the past ten years.

What is the share price of Godavari Drugs Ltd (530317)?

Company share prices are keep on changing according to the market conditions. The current trading price of Godavari Drugs Ltd (530317) on 04-Jun-2026 16:59:59 at 16:59 is 122.50.

What is the P/E ratio of Godavari Drugs?

The latest standalone P/E ratio of Godavari Drugs as of 04-Jun-2026 is 30.35.

What is the P/B ratio of Godavari Drugs Ltd (530317)?

The latest standalone P/B ratio of Godavari Drugs Ltd (530317) as of 04-Jun-2026 is 1.76.

What is the 52-week high and low of Godavari Drugs Ltd (530317)?

The 52-week high of Godavari Drugs Ltd (530317) is Rs. 135.25 and the 52-week low is Rs. 69.70.

Godavari Drugs Ltd (530317) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Godavari Drugs Ltd (530317)
Brand: Godavari Drugs

Godavari Drugs Ltd (530317)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530317 NSE: Pharmaceuticals & Drugs | Small Cap | Godavari Drugs Share Price

Godavari Drugs Ltd (530317)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530317 NSE: Pharmaceuticals & Drugs | Small Cap | Godavari Drugs Share Price

Key Metrics

Valuation Multiples

Market Cap

₹124 Cr.

Current Price

₹122.5

52-Week Low / High

₹70 / 135

TTM EPS

₹4

TTM Sales

₹106 Cr.

Book Value per Share

₹69.7

P/E Ratio

30.35

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

1.76

Lower than its 5-year historical median

Price to Sales (P/S)

1.17

Higher than its 5-year historical median

EV/EBITDA

16.72

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

10.64%

Outperforms industry median

Return on Capital Employed (ROCE)

10.13%

Underperforms industry median

Return on Assets (ROA)

3.15%

Operating Profit Margin

10.7%

Net Profit Margin

3.86%

Gross Profit Margin

7.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-27.67%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-11.05%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-21.08%

Asset Quality

Promoter Holding

40.23%

Pledged shares (%) of Promoter's holding (%)

0.21%

Reserves

₹60 Cr.

Equity

₹10.1 Cr.

Face Value

₹10

All Time Low / High

₹1.00 / 155.00

Godavari Drugs stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Godavari Drugs Ltd a good quality company?

Godavari Drugs Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Godavari Drugs Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Godavari Drugs Ltd vs industry peers?

Godavari Drugs Ltd revenue CAGR is 3.44%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Godavari Drugs Ltd?

Promoters hold 40.23% of the Godavari Drugs Ltd, with 0.21% of their stake pledged, indicating low pledge risk.

Q.1 Stock return of Godavari Drugs Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 11.2% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	15.8%	16.9%	11%	12.1%	11.8%	17.6%	18.4%	12.4%	12.6%	10.1%	-
Value Creation Index ⓘ	0.1	0.2	-0.2	-0.1	-0.2	0.3	0.3	-0.1	-0.1	-0.3	-
Growth Parameters ⓘ
Sales ⓘ	71.1	75.6	64.5	83.5	95.7	123	161	160	157	113	106
Sales YoY Gr.	-	6.3%	-14.8%	29.6%	14.6%	28.2%	31.3%	-0.9%	-1.8%	-27.7%	-
Adj EPS ⓘ	1.7	1.7	0.8	1.6	2.6	5.3	7.2	6.5	7.6	6.1	4
YoY Gr.	-	2.4%	-53.2%	91.4%	68.4%	103.5%	35.2%	-9.6%	17.1%	-20.1%	-
BVPS (₹) ⓘ	19.1	21.5	22.6	24.2	26.9	32.4	39.4	44.4	51.7	57.6	69.7
Adj Net Profit ⓘ	1.3	1.3	0.6	1.2	2	4	5.4	4.9	5.7	4.6	4
Cash Flow from Ops. ⓘ	-4.5	5.2	3.8	3.7	6.2	1.3	11.2	13.2	18.4	11.2	-
Debt/CF from Ops. ⓘ	-3.4	3.1	5	5.9	4.4	22.9	2.1	4.3	3.1	5.8	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.3%	3.4%	-11.1%	-27.7%
Adj EPS ⓘ	15.3%	18.4%	-5.4%	-20.1%
BVPSⓘ	13%	16.4%	13.5%	11.3%
Share Price	11.8%	15.8%	11.2%	26.5%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	9.3	8.5	3.7	6.6	10.2	17.9	20	15.5	15.8	11.1	6.4
Op. Profit Mgn % ⓘ	6.4	7	6.3	6.6	6.3	8	7.2	7.4	8.6	10.7	9.8
Net Profit Mgn % ⓘ	1.8	1.7	1	1.4	2.1	3.3	3.4	3.1	3.7	4	3.9
Debt to Equity ⓘ	1.1	1	1.1	1.2	1.4	1.3	0.8	1.7	1.5	1.5	0.5
Working Cap Days ⓘ	154	180	249	221	219	188	157	179	200	266	150
Cash Conv. Cycle ⓘ	58	60	78	72	75	70	50	82	113	135	21

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	71	76	64	84	96	123	161	160	157	113
Operating Expenses ⓘ +	67	70	60	78	90	113	150	150	143	102
Manufacturing Costs	4	7	5	6	6	8	10	10	12	10
Material Costs	59	59	49	65	77	97	130	128	121	82
Employee Cost	2	2	3	3	3	4	5	5	5	5
Other Costs ⓘ	2	2	3	4	3	4	5	7	6	4
Operating Profit ⓘ	4	5	4	5	6	10	11	10	13	12
Operating Profit Margin (%)	6.3%	6.9%	6.3%	6.6%	6.3%	8.0%	7.0%	6.2%	8.5%	10.4%
Other Income ⓘ +	0	1	1	0	0	0	0	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-0	0
Interest ⓘ	2	3	2	3	3	3	3	4	5	5
Depreciation ⓘ	1	1	1	1	1	1	2	2	2	2
Profit Before Tax ⓘ	2	3	1	2	2	6	7	5	7	6
Tax ⓘ	1	1	0	1	0	2	2	1	1	1
Profit After Tax	1	2	1	1	2	4	5	4	6	4
PAT Margin (%)	1.9%	2.4%	1.3%	1.5%	2.1%	3.4%	3.3%	2.4%	3.5%	3.9%
Adjusted EPS (₹)	1.8	2.4	1.1	1.6	2.7	5.5	7.0	5.0	7.4	5.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Godavari Drugs - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	14	16	17	18	20	24	30	33	39	43
Share Capital ⓘ	8	8	8	8	8	8	8	8	8	8
Reserves ⓘ	7	9	10	11	13	17	22	26	31	36
Debt +	15	16	18	21	26	28	20	55	56	62
Long Term Debt	4	4	7	8	11	14	12	12	11	24
Short Term Debt	12	11	12	13	15	14	9	43	44	38
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	17	20	23	30	30	30	43	25	32	29
Others Liabilities ⓘ	3	4	5	4	7	9	8	8	9	9
Total Liabilities ⓘ	51	56	63	74	84	91	101	121	135	143
Fixed Assets
Net Fixed Assets ⓘ +	9	13	15	15	14	22	26	25	27	33
Gross Block	25	30	33	34	34	44	50	46	47	49
Accumulated Depreciation	16	17	18	19	20	22	23	21	20	17
CWIP ⓘ	1	0	1	2	9	1	0	9	18	30
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	11	11	13	16	18	15	10	20	21	28
Trade Receivables	25	24	27	34	36	45	56	58	59	42
Cash Equivalents	1	1	2	2	1	2	2	3	3	2
Others Assets ⓘ	5	6	6	5	6	7	7	7	7	8
Total Assets ⓘ	51	56	63	74	84	91	101	121	135	143

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-5	5	4	4	6	1	11	13	18	11
PBT ⓘ	1	3	1	6	2	6	7	5	7	6
Adjustment ⓘ	1	3	3	-0	4	4	4	5	6	6
Changes in Working Capital ⓘ	-6	0	0	-1	1	-7	2	4	6	1
Tax Paid ⓘ	0	-1	-1	-0	-0	-2	-2	-1	-1	-1
Cash Flow From Investing Activity ⓘ +	-2	-3	-3	-2	-7	-1	-5	-9	-13	-20
Capex	-2	-4	-4	-3	-7	-2	-5	-9	-13	-20
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	1	1	0	0	0	0	1	-0	0
Cash Flow From Financing Activity ⓘ +	7	-2	-0	-1	0	0	-6	-4	-6	8
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	2	1	3	3	-3	0	-1	13
Interest Paid ⓘ	0	-3	-2	-3	-3	-3	-3	-4	-5	-5
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	7	0	0	0	0	0	-0	-0	0	0
Net Cash Flow ⓘ	0	0	1	-0	-0	0	1	1	-0	-0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	9.84	11.81	4.99	6.85	10.39	18.49	19.42	12.01	15.33	10.64
ROCE (%)	15.77	16.89	11.01	12.14	11.8	17.58	18.35	12.36	12.63	10.13
Asset Turnover Ratio	1.86	1.56	1.09	1.22	1.21	1.4	1.67	1.43	1.22	0.82
PAT to CFO Conversion(x)	-5	2.5	4	4	3	0.25	2.2	3.25	3	2.75
Working Capital Days
Receivable Days	86.80	107.30	144.30	132.70	133.40	120.70	114.10	129.80	136.70	163.80
Inventory Days	46.10	48.60	70.20	65.40	65.30	48.20	28	34.20	47.20	78.20
Payable Days	81.30	115.90	159.60	150.10	144.30	113	101.90	96.90	85.10	134.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

1.25

0.25

0.22

0.21

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Godavari Drugs Ltd FAQs

The current trading price of Godavari Drugs on 04-Jun-2026 16:59 is ₹122.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Godavari Drugs stood at ₹124.1 Cr

The latest P/E ratio of Godavari Drugs as of 03-Jun-2026 is 30.35.

The latest P/B ratio of Godavari Drugs as of 03-Jun-2026 is 1.76.

The 52-week high of Godavari Drugs is ₹135.2 and the 52-week low is ₹69.70.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Godavari Drugs is ₹106 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Godavari Drugs Ltd is a average quality company.

The key valuation ratios of Godavari Drugs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Godavari Drugs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Godavari Drugs Ltd

Godavari Drugs was incorporated as a private limited company on December 2, 1987 and subsequently converted into a public limited company on September 25, 1992. It was promoted by Ghanshyam Jaju, Mukund Kakani and PC Shrimal.

The company has set up a project to manufacture 180 TPA at Sulphamethoxazole (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class â€˜Câ€™ backward district in Maharashtra. The project was fully commissioned on July 3, 1989.

The registered office of the company is located at Secunderabad in Andhra Pradesh and Mukund Kakani is its Managing Director.

Business area of the company

The companyâ€™s principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Godavari Drugs Ltd (530317)

Godavari Drugs Ltd (530317)

Godavari Drugs stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Godavari Drugs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Godavari Drugs Ltd FAQs

About Godavari Drugs Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Godavari Drugs Ltd (530317)

Godavari Drugs Ltd (530317)

Godavari Drugs stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Godavari Drugs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Godavari Drugs Ltd FAQs

What is the share price of Godavari Drugs?

What is the market cap of Godavari Drugs?

What is the P/E ratio of Godavari Drugs?

What is the P/B ratio of Godavari Drugs?

What is the 52-week high and low of Godavari Drugs?

What is the TTM revenue of Godavari Drugs?

Is Godavari Drugs Ltd a good quality company?

Is Godavari Drugs Ltd undervalued or overvalued?

Is Godavari Drugs Ltd a good buy now?

About Godavari Drugs Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.